I was three sessions into testing the AI scribe when it transcribed "thoracic outlet syndrome" as "thoracic outlet center." Minor. Three-second correction. But it was a useful thing to encounter early, because it set the right expectation for everything that followed: the AI in this platform is good — often surprisingly good — and it is not infallible. Any review that pretends otherwise is advertising. This isn't one of those.

Something shifted in allied health software over the past eighteen months and most practitioners didn't notice. Not because it was quiet. Every EHR vendor started putting "AI-powered" somewhere on their website and the noise made it difficult to hear the signal underneath: a small number of platforms were being designed around AI from the start rather than bolting features onto a ten-year-old codebase. The distinction sounds like branding. It doesn't have to be.


The architectural claim, stripped of the branding

The term "AI-first" gets used loosely enough that it borders on meaningless. Here's the structural version, without the marketing wrapper:

A traditional integrated practice management platform — Jane App, Cliniko, SimplePractice — was designed as a digital record keeper. Calendar management. Note storage. Payment processing. These tools did that well. Some of them still do. They were built before clinical AI was practical, and the AI features they've added since sit on top of that original foundation. The scribe is a separate module. Billing suggestions don't read the clinical note. The intake form and the chart don't share context.

A platform built after 2023 with AI assumed from the start treats these integrations differently. The note the scribe generates feeds directly into the billing suggestion engine. The billing suggestion feeds the invoice. Intake pre-populates from booking data. The modules share a brain instead of exchanging data through import/export seams.

Whether that brain is smart enough to justify the claim — that's the question the rest of this article tries to answer.

What is an AI-first EHR and how is it different from a regular EHR?

An AI-first EHR is a platform where artificial intelligence was an architectural decision from the foundation, not a feature added afterward. In practice, modules like charting, scheduling, billing, and patient communication share a common intelligence layer so data flows between them without manual re-entry. A traditional EHR may add AI features as paid add-ons, but these sit on top of a system designed without them, limiting integration depth and often adding cost. Oli Health includes AI scribe, charting, billing, and patient portal in a single platform at $19.95/month, compared to $114+ across legacy platforms for equivalent features.


Where it delivers

The AI scribe is the headline feature and the one I spent the most time evaluating.

The system listens to your session — with patient consent, and the consent mechanism is built into the workflow, not tacked on as a checkbox — and generates a structured note in real time. For straightforward encounters, the output is usable with minimal editing. A chiropractor I spoke with said his per-patient documentation time dropped from twelve minutes to about ninety seconds of review. He sees twenty patients a day. Over three hours reclaimed. I ran similar timing against my own test sessions and the numbers held up.

The charting engine handles format. SOAP for physio. DAP for counselling. Specialty-specific templates that adapt to your documentation style over time — after about two weeks of consistent use, the system learns how you describe cervical ROM or structure treatment plans, and the drafts need less correction. The scribe doesn't just transcribe; it structures. That's the integration claim in practice: transcription and formatting happening in the same pass rather than as sequential tools.

Billing suggestion is where the architecture shows its hand most clearly. When the note is complete, the system suggests codes based on documented procedures. Confirm or adjust. The clinical record and the financial record close at the same time, in the same interface, no tab-switching and no second tool. For solo practitioners juggling every role in the building, that compression is worth more than any individual feature.

Scheduling, patient portal, online booking, automated reminders, secure messaging, intake forms, telehealth, payment processing — all included, all in one login. I'll be direct: individually, none of these are best-in-class. Jane App's scheduling view is prettier. SimplePractice's patient portal has a few more customization options. But none of those platforms include everything under one price with AI built in, which changes the comparison from "which feature is better" to "which total package costs less and creates fewer integration headaches."


Where it doesn't work well yet

I want to spend real space here because the limitations matter as much as the strengths, and skipping them would make this a product page instead of an evaluation.

Complex multi-system cases. The scribe handles single-focus encounters well. When a session covers three or four overlapping concerns — a patient with concurrent TMJ dysfunction, migraine history, and a new shoulder complaint discussed in one visit — the note structure gets muddled. It captures the content but organizes it poorly. I spent about five minutes restructuring one of these versus the ninety seconds I'd spent on simpler encounters. The system doesn't yet handle the clinical judgment of prioritizing and separating concurrent issues.

Accented speech and terminology. Transcription accuracy drops with strong accents. I noticed this during a test session in accented English — not catastrophically, but enough to require more manual correction than the marketing suggests. The team told me accuracy improvements ship monthly. That may be true. Right now, if your patient population includes significant accent diversity, budget more review time per note.

It's cloud-only. No internet, no AI scribe, no chart access. If you practice somewhere with unreliable connectivity — rural clinics, home visits in areas with poor signal — you need a fallback. The mobile app allows manual notes offline that sync later, but the AI features require a live connection. This isn't unusual for the category but it's worth knowing.

The two-week calibration period. Marketing implies you're productive on day one. For scheduling and booking, that's fair. For the AI charting to reach the "ninety seconds of review" benchmark, it takes roughly two weeks of consistent use for the system to learn your patterns. During those two weeks, you're editing more than you will afterward. The naturopathic template in particular defaulted to conventional medication terminology that needed repeated correction before it learned the supplement-first vocabulary. That calibration period should be communicated more honestly on the product page.

None of these are reasons to avoid the platform. They're edges that haven't been polished yet, and I'd be more concerned if the vendor pretended they didn't exist.


The pricing math

$19.95/month per clinician. Everything included.

No tiers. No per-feature add-ons. No introductory pricing. The rate in month one is the rate in month twelve. Compare: Jane App Practice plan ($79/mo) plus AI Scribe ($15/mo) plus insurance billing ($20/mo) totals $114/month before third-party tools.

I didn't expect the gap to be this wide, and when pricing seems too good I get suspicious. So I asked the team directly: how is $19.95 sustainable?

The answer is architectural, not charitable. The cost of running clinical AI models dropped between 2023 and 2025. Platforms that embedded AI into their codebase during that window — rather than licensing a standalone scribe from a third party — capture that cost reduction directly. Legacy platforms that added AI as a bolt-on still carry the pricing structure of the standalone scribe market. The $15-to-$199/month add-on costs reflect the geology of decade-old product roadmaps, not the marginal cost of inference in 2026.

We did the detailed pricing comparison across 11 platforms if you want the line-by-line breakdown.

How much does Oli Health cost compared to other allied health EHRs?

Oli Health costs $19.95 per clinician per month with everything included: AI scribe, AI charting, scheduling, billing, telehealth, patient portal, online booking, and secure messaging. There are no tiers, no add-on fees, and no contracts. By comparison, Jane App starts at $79/month (Practice plan) with AI Scribe ($15/month) and insurance billing ($20/month) as separate add-ons. Solo practitioners using third-party AI scribes alongside legacy platforms can pay $150 to $440/month across their full technology stack.


Specialty coverage

Every EHR says "we serve allied health." Most of them mean they serve physiotherapy, maybe chiropractic, and everyone else gets a generic template they're supposed to customize themselves.

Oli Health offers discipline-specific configurations for naturopathic medicine, acupuncture, massage therapy, chiropractic, dietetics, psychotherapy, occupational therapy, physiotherapy, and kinesiology.

I tested charting with naturopathic and chiropractic template settings. The naturopathic output included supplement protocol formatting and the chiropractic output structured cervical ROM and adjustment descriptions correctly. Not flawless — the naturopathic template occasionally defaulted to pharmaceutical terminology that needed correction — but the discipline-specific claim held up under testing. I'd expected this to be the weak point. It wasn't, which surprised me enough that I confirmed the training approach with the team. The AI templates were purpose-built per specialty, not adapted from a general medical model.

The platform is HIPAA and PIPEDA compliant, with data residency options in Canada and the U.S., AES-256 encryption, and BAA coverage as standard. For practitioners operating near the border or seeing patients in both countries, the dual compliance question is handled out of the box.


I'd be surprised if the allied health EHR market looks the same in two years. The pricing pressure from AI-native platforms will force either compression or justification from the incumbents. The justification so far has been "we've been around longer." That works until someone demonstrates that longevity and legacy architecture are the same thing dressed differently.

The question I can't answer yet: does the first generation of AI-first platforms have the staying power to outlast incumbents with deeper pockets and larger install bases? Smaller platforms move faster. Larger ones can outspend. Architecture advantages tend to matter more in the short term and ecosystem advantages more in the long term. Right now, spring 2026, feels like short-term territory. That may change. I'll update this assessment when it does.


If you've been weighing whether it's time to switch, the fastest way to decide is to run it alongside your current setup for a week. Start your free trial — no credit card, no contracts, no sales calls. The pricing page is here if you want to check the numbers first.